Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньювейшн Байо Инк.filedCriticalНьювейшн Байо Инк.
Priority claimed from PCT/US2020/014206external-prioritypatent/WO2020150674A1/en
Publication of EA202192006A1publicationCriticalpatent/EA202192006A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Представлены соединения аминопиразина в качестве модуляторов аденозинового рецептора. Соединения могут найти применение в качестве терапевтических агентов для лечения заболеваний, опосредованных через сигнальный путь рецептора, сопряженного с G-белком, и могут найти конкретное применение в онкологии.Aminopyrazine compounds are presented as adenosine receptor modulators. The compounds may find use as therapeutic agents for the treatment of diseases mediated through the G-protein coupled receptor signaling pathway and may find particular use in oncology.
EA202192006A2019-01-232020-01-17
HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
EA202192006A1
(en)